{"id":52864,"date":"2023-01-12T17:02:16","date_gmt":"2023-01-12T16:02:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/1361-9-prescription-drugs-markets-global-forecasts-from-2022-to-2027-researchandmarkets-com\/"},"modified":"2023-01-12T17:02:16","modified_gmt":"2023-01-12T16:02:16","slug":"1361-9-prescription-drugs-markets-global-forecasts-from-2022-to-2027-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/1361-9-prescription-drugs-markets-global-forecasts-from-2022-to-2027-researchandmarkets-com\/","title":{"rendered":"$1,361.9 Prescription Drugs Markets – Global Forecasts from 2022 to 2027 – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Global Prescription Drugs Market – Forecasts from 2022 to 2027”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global prescription drug market is estimated to augment at a CAGR of 4.98% increasing from USD969.305 billion in 2020 to USD1,361.905 billion by the end of 2027.\n<\/p>\n

\nGrowing global pharmaceutical spending will have a significant impact on fueling the market growth during the forecast period. One of the main drivers is the high cost of speciality medicines and the growing use of medical treatments. The prevalence of rare disorders is further propelling the market demand during the forecast period.\n<\/p>\n

\nThe increasing number of chronic diseases worldwide is further continuing to increase the sales of prescription drugs in the forecast period. The growing number of cancer incidences worldwide is driving the market growth during the forecast period. The novel coronavirus pandemic scenario has had a positive impact on fueling the market growth in 2020.\n<\/p>\n

\nIt is, however, at a lower growth rate than the previous year. The market for prescription drugs will further proliferate with the research and development investments among companies for the manufacturing of innovative drugs. Hence, the presence of pipeline drugs indicates that a greater number of drugs are capable of gaining commercialization in the near future, further providing an opportunity for the market to thrive during the forecast period.\n<\/p>\n

\nFurthermore, the growing number of elderly individuals worldwide has significantly raised market growth prospects in the forecast period. The developed regions of the world, particularly, North America, are projected to hold a significant market share in the global prescription drug market.\n<\/p>\n

\nOn the other hand, the Asia-Pacific region is regarded as one of the fastest-growing, owing to the prevalence of a large population base in need of treatment. In addition, significant investments in improving healthcare infrastructure with better health facilities are further providing an opportunity for the market to grow during the forecast period.\n<\/p>\n

\nThe use of generics as prescription medicines and companies offering generic drugs are further providing an impetus to propel the market growth in the forecast period. One of the leaders in generics, Teva Pharmaceuticals states that in the United States of America, the company is the pioneer in generic pharmaceuticals. In the US, one out of every nine drugs prescribed is filled by Teva products.\n<\/p>\n

\nIn the United Kingdom, it is observed that one out of six individuals is prescribed Teva generics. Additionally, other companies manufacturing prescription medicines utilize Teva pharmaceutical’s active pharma ingredients. One of the benefits provided by generic medicines includes that they are quite affordable for patients in comparison to branded drugs.\n<\/p>\n

\nIt is noticed on a wide scale that generic medicines, on average, cost between 80 and 85% less than branded drugs. In the USA, generic medicines account for around 90% of the total prescribed medicines. It is estimated to hold approximately 78% of the market in Germany. The growing chronic diseases worldwide are propagating the market growth in the forecast period.\n<\/p>\n

\nIt has been observed on a wide scale that there is a significant rise in the global chronic disease burden. One of the major reasons includes growing urbanization and the adoption of unhealthy living conditions. Also, the growing geriatric population worldwide is contributing to the growth of age-associated diseases, further augmenting the chronic disease growth and further fueling the market growth in the forecast period.\n<\/p>\n

\nDiseases such as Alzheimer’s disease, cardiovascular disease, obesity, and diabetes are some chronic diseases. The rising incidences of cancer are further providing an impetus, fueling the market growth in the forecast period. As per the World Health Organization, 2018, information, cancer is the second leading cause of death in the world. In 2018, it was responsible for 9.6 million deaths. Also, around one in six deaths in the world occurs due to cancer. The most common cancers include lung cancer, breast cancer, colorectal cancer, prostate cancer, skin cancer, and stomach cancer. The total number of new cases in 2018 has grown to 18.1 million.\n<\/p>\n

\nAccording to the organization’s global analysis, Europe accounted for 23.4% of the global total number of cancer cases in 2018. While it was responsible for 20.3% of all cancer deaths worldwide, The Americas accounted for 21% of global cancer incidence while accounting for 14.4% of global cancer mortality. . Asia accounted for 48.4% of global cancer incidences, while, it held a share of 57.3% in global cancer deaths. Africa held a share of 5.8% in the global cancer incident cases, while it accounted for 7.3% of the global cancer deaths.\n<\/p>\n

\nThe growing prevalence of cardiovascular diseases is further contributing to the sales of prescription drugs, fueling the market growth in the forecast period. As per the CDC, cardiovascular diseases, comprising disorders of the heart and blood vessels, are ranked as the number one cause of death and disability globally.\n<\/p>\n

\nThe major risk factors for this disease include high blood pressure or hypertension, which are attributed to causing a predicted 10 million deaths globally every year. Several initiatives, such as the Global Hearts Initiative, are being taken for the improvement of the prevention and control of cardiovascular diseases worldwide. This is for the reduction of premature deaths occurring from heart diseases.\n<\/p>\n

\nCovid-19 Impact:<\/strong>\n<\/p>\n

\nCovid-19 pandemic has positively impacted the overall market growth owing to the increased approvals of speciality medications, increasing R&D investments by key players and growing demand for effective immunity-building drugs across the globe. COVID-19 increased the revenue generation opportunity for players in the global prescription drugs market.\n<\/p>\n

\nThe companies across the globe are getting into collaborations and mergers with the various research institutes and manufacturers is another key factor which has contributed to the overall market growth in 2020. There was a high demand for various prescription drugs to fight against infectious diseases, diabetes, influenza etc. during and after the pandemic.\n<\/p>\n

\nKey Developments:<\/strong>\n<\/p>\n